Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-06

FDA Approved: CHOLESTYRAMINE — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved Ajanta Pharma USA's original application for a generic cholestyramine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cholestyramine (cholestyramine)

Snippet

ORIG AP for CHOLESTYRAMINE (CHOLESTYRAMINE)